Hostname: page-component-74656f9884-6grmk Total loading time: 0 Render date: 2026-11-06T04:57:05.410Z Has data issue: false hasContentIssue false

Methoprene treatment and its effect on male reproductive organ size and female remating in a fruit fly

Published online by Cambridge University Press:  20 January 2023

L. A. Giudice
Affiliation:
Laboratorio de Investigaciones Ecoetológicas de Moscas de la Fruta y sus Enemigos Naturales (LIEMEN), PROIMI-Biotecnología, CONICET, Tucumán CP 4000, Argentina
V. Díaz
Affiliation:
Laboratorio de Investigaciones Ecoetológicas de Moscas de la Fruta y sus Enemigos Naturales (LIEMEN), PROIMI-Biotecnología, CONICET, Tucumán CP 4000, Argentina
A. Moyano
Affiliation:
Laboratorio de Investigaciones Ecoetológicas de Moscas de la Fruta y sus Enemigos Naturales (LIEMEN), PROIMI-Biotecnología, CONICET, Tucumán CP 4000, Argentina
D. Pérez-Staples
Affiliation:
INBIOTECA, Universidad Veracruzana, Av. de las Culturas Veracruzanas 101, Col. E. Zapata, Xalapa, Veracruz CP 91090, Mexico
S. Abraham*
Affiliation:
Laboratorio de Investigaciones Ecoetológicas de Moscas de la Fruta y sus Enemigos Naturales (LIEMEN), PROIMI-Biotecnología, CONICET, Tucumán CP 4000, Argentina
*
Author for correspondence: S. Abraham, Email: solanaabraham@yahoo.com.ar
Rights & Permissions [Opens in a new window]

Abstract

Methoprene, a juvenile hormone analog, is used to accelerate sexual maturation in males of species of economic importance in support to the sterile insect technique (SIT). In the SIT, mass-reared sterile males are released into the field and need to survive until they reach sexual maturation, find a wild female, mate with her and then induce female sexual refractoriness, so she will not remate with a wild counterpart. The use of methoprene shortens the time between release and copulation. However, in South American fruit flies, Anastrepha fraterculus, the ability of methoprene-treated males to inhibit female remating has been shown to be lower than wild males, when methoprene was applied by pupal immersion or topical application. Here we evaluated the possibility of incorporating methoprene into the male diet at different doses and the ability of those males to inhibit female remating, as well as the effect of methoprene on male reproductive organ size, due to the possible correlation between male accessory gland size and their content, and the role of male accessory gland proteins in female inhibition. We found that A. fraterculus males fed with methoprene in the adult protein diet at doses as high as 1% were less likely to inhibit female remating, however, at all other lower doses males had the same ability as untreated males to inhibit female remating. Males fed with methoprene had bigger male accessory glands and testes compared to methoprene-deprived males. We demonstrate that the incorporation of methoprene in adult male diets is possible in this species and potentially useful as a post-teneral, pre-release supplement at doses as low as 0.01%. Even at higher doses, the percentage of females remating after 48 h from the first copulation is sufficiently low in this species so as not compromise the efficiency of the SIT.

Information

Type
Research Paper
Copyright
Copyright © The Author(s), 2023. Published by Cambridge University Press
Figure 0

Figure 1. Testes size (area, mean ± SE) of virgin A. fraterculus males of different ages treated with methoprene or untreated (control). Different uppercase letters indicate significant differences between ages and different lowercase letters indicate differences between treated or untreated males (two-way ANOVA, P < 0.05).

Figure 1

Figure 2. Male accessory gland size (area, mean ± SE) of virgin A. fraterculus males of different ages treated with methoprene or untreated (control). Different uppercase letters indicate significant differences between ages and different lowercase letters indicate differences between treated or untreated males (two-way ANOVA, P < 0.05).

Figure 2

Figure 3. Trial 1. Percentage of male mating success (mean + SE) and female remating (mean + SE) at 48 h of first copulation of A. fraterculus females mated with untreated control males (6/12 days old) or methoprene-treated males (6/12 days old) at 0.01% (methoprene applied in solution). Numbers inside bars represent sample sizes. Different letters indicate significant differences (ANOVA, P < 0.05).

Figure 3

Figure 4. Trial 2. Percentage of male mating success (mean + SE) and female remating (mean + SE) at 48 h of first copulation of A. fraterculus females mated with untreated control males (6/12 days old) or 6-day-old methoprene-treated males at four different doses (0.1, 0.05, 0.02, and 0.01%, methoprene applied in solution). Numbers inside bars represent sample sizes. Different letters indicate significant differences (ANOVA, P > 0.05).

Figure 4

Figure 5. Trial 3. Percentage of male mating success (mean + SE) and female remating (mean + SE) at 48 h of first copulation of A. fraterculus females mated with untreated control males (6/12 days old) or 6-day-old methoprene-treated males at four different doses (1, 0.5, 0.1, and 0.01%, direct placement of methoprene in diet). Numbers inside bars represent sample sizes. Different letters indicate significant differences (ANOVA, P < 0.05).